146 related articles for article (PubMed ID: 24433336)
1. Excess adiposity and survival in patients with colorectal cancer: a systematic review.
Parkin E; O'Reilly DA; Sherlock DJ; Manoharan P; Renehan AG
Obes Rev; 2014 May; 15(5):434-51. PubMed ID: 24433336
[TBL] [Abstract][Full Text] [Related]
2. Pre-diagnostic body mass index and weight change in relation to colorectal cancer survival among incident cases from a population-based cohort study.
Laake I; Larsen IK; Selmer R; Thune I; Veierød MB
BMC Cancer; 2016 Jul; 16():402. PubMed ID: 27387027
[TBL] [Abstract][Full Text] [Related]
3. Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
Becerra-Tomás N; Markozannes G; Cariolou M; Balducci K; Vieira R; Kiss S; Aune D; Greenwood DC; Dossus L; Copson E; Renehan AG; Bours M; Demark-Wahnefried W; Hudson MM; May AM; Odedina FT; Skinner R; Steindorf K; Tjønneland A; Velikova G; Baskin ML; Chowdhury R; Hill L; Lewis SJ; Seidell J; Weijenberg MP; Krebs J; Cross AJ; Tsilidis KK; Chan DSM
Int J Cancer; 2024 Aug; 155(3):400-425. PubMed ID: 38692659
[TBL] [Abstract][Full Text] [Related]
4. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).
Caan BJ; Meyerhardt JA; Kroenke CH; Alexeeff S; Xiao J; Weltzien E; Feliciano EC; Castillo AL; Quesenberry CP; Kwan ML; Prado CM
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1008-1015. PubMed ID: 28506965
[No Abstract] [Full Text] [Related]
5. Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.
Lee CS; Murphy DJ; McMahon C; Nolan B; Cullen G; Mulcahy H; Sheahan K; Barnes E; Fennelly D; Ryan EJ; Doherty GA
J Gastrointest Cancer; 2015 Sep; 46(3):243-50. PubMed ID: 25832480
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.
Doleman B; Mills KT; Lim S; Zelhart MD; Gagliardi G
Tech Coloproctol; 2016 Aug; 20(8):517-35. PubMed ID: 27343117
[TBL] [Abstract][Full Text] [Related]
7. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis.
Prentice P; Viner RM
Int J Obes (Lond); 2013 Aug; 37(8):1036-43. PubMed ID: 23164700
[TBL] [Abstract][Full Text] [Related]
8. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study.
Keimling M; Renehan AG; Behrens G; Fischer B; Hollenbeck AR; Cross AJ; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1383-94. PubMed ID: 23720402
[TBL] [Abstract][Full Text] [Related]
9. Body fatness at an early age and risk of colorectal cancer.
Hidayat K; Yang CM; Shi BM
Int J Cancer; 2018 Feb; 142(4):729-740. PubMed ID: 29023686
[TBL] [Abstract][Full Text] [Related]
10. Prediagnosis body mass index and waist-hip circumference ratio in association with colorectal cancer survival.
Wang N; Khankari NK; Cai H; Li HL; Yang G; Gao YT; Xiang YB; Shu XO; Zheng W
Int J Cancer; 2017 Jan; 140(2):292-301. PubMed ID: 27706816
[TBL] [Abstract][Full Text] [Related]
11. Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.
Renfro LA; Loupakis F; Adams RA; Seymour MT; Heinemann V; Schmoll HJ; Douillard JY; Hurwitz H; Fuchs CS; Diaz-Rubio E; Porschen R; Tournigand C; Chibaudel B; Falcone A; Tebbutt NC; Punt CJ; Hecht JR; Bokemeyer C; Van Cutsem E; Goldberg RM; Saltz LB; de Gramont A; Sargent DJ; Lenz HJ
J Clin Oncol; 2016 Jan; 34(2):144-50. PubMed ID: 26503203
[TBL] [Abstract][Full Text] [Related]
12. Recurrence dynamics of breast cancer according to baseline body mass index.
Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
[TBL] [Abstract][Full Text] [Related]
13. Anthropometry-based Obesity Phenotypes and Risk of Colorectal Adenocarcinoma: A Large Prospective Cohort Study in Norway.
Lu Y; Ness-Jensen E; Martling A; Hveem K
Epidemiology; 2016 May; 27(3):423-32. PubMed ID: 26808598
[TBL] [Abstract][Full Text] [Related]
14. Incident cancer burden attributable to excess body mass index in 30 European countries.
Renehan AG; Soerjomataram I; Tyson M; Egger M; Zwahlen M; Coebergh JW; Buchan I
Int J Cancer; 2010 Feb; 126(3):692-702. PubMed ID: 19645011
[TBL] [Abstract][Full Text] [Related]
15. Is obesity an advantage in patients with colorectal cancer?
Kasi PM; Zafar SY; Grothey A
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1339-42. PubMed ID: 26366838
[TBL] [Abstract][Full Text] [Related]
16. The impact of anthropometric parameters on colorectal cancer prognosis: A systematic review and meta-analysis.
Jaspan V; Lin K; Popov V
Crit Rev Oncol Hematol; 2021 Mar; 159():103232. PubMed ID: 33497759
[TBL] [Abstract][Full Text] [Related]
17. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Schlesinger S; Lieb W; Koch M; Fedirko V; Dahm CC; Pischon T; Nöthlings U; Boeing H; Aleksandrova K
Obes Rev; 2015 Jul; 16(7):607-19. PubMed ID: 25925734
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
